awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42535426-F6C1D45B-8E6C-43B2-916E-602458B924B7
Q42535426-F6C1D45B-8E6C-43B2-916E-602458B924B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42535426-F6C1D45B-8E6C-43B2-916E-602458B924B7
Vonoprazan: MarKed Competition for PPIs?
P2860
Q42535426-F6C1D45B-8E6C-43B2-916E-602458B924B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42535426-F6C1D45B-8E6C-43B2-916E-602458B924B7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a4c1d678d44ebf87c9e68ebe98de6f7f6adef20e
P2860
Characterization of a novel potassium-competitive acid blocker of the gastric H,K-ATPase, 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438).